151 related articles for article (PubMed ID: 1126756)
1. Absorption of blocking activity from human tumor-bearer sera by Staphylococcus aureus, Cowan I.
Steele G; Ankerst J; Sjögren HO; Vang J; Lannerstad O
Int J Cancer; 1975 Feb; 15(2):180-9. PubMed ID: 1126756
[TBL] [Abstract][Full Text] [Related]
2. Alteration of in vitro anti-tumor activity of tumor-bearer sera by absorption with Staphylococcus aureus, Cowan I.
Steele G; Ankerst J; Sjögren HO
Int J Cancer; 1974 Jul; 14(1):83-92. PubMed ID: 4376510
[No Abstract] [Full Text] [Related]
3. The effects of cyclophosphamide on in vitro correlates of tumor immunity.
Steele G; Sjögren HO; Ankerst J
Int J Cancer; 1974 Dec; 14(6):743-52. PubMed ID: 4377004
[TBL] [Abstract][Full Text] [Related]
4. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
5. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
Steele G; Sjögren HO; Lannerstad O; Stadenberg I
Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
[TBL] [Abstract][Full Text] [Related]
6. Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci.
Kronvall G; Simmons A; Myhre EB; Jonsson S
Infect Immun; 1979 Jul; 25(1):1-10. PubMed ID: 383609
[TBL] [Abstract][Full Text] [Related]
7. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
Steele G; Sjögren HO; Stadenberg I
Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
Carrel S; Delisle MC; Mach JP
Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
[TBL] [Abstract][Full Text] [Related]
9. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
Saiki O; Ralph P
Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
[TBL] [Abstract][Full Text] [Related]
10. K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins.
Hammarström S; Troye M; Wahlund G; Svenberg T; Perlmann P
Int J Cancer; 1977 Jun; 19(6):756-66. PubMed ID: 873641
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
Pollack SB; Nelson K
Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
[TBL] [Abstract][Full Text] [Related]
12. A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus.
Ankerst J; Christensen P; Kjellén L; Kronvall G
J Infect Dis; 1974 Sep; 130(3):268-73. PubMed ID: 4411735
[No Abstract] [Full Text] [Related]
13. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.
Hakim AA
Klin Wochenschr; 1975 Sep; 53(18):881-3. PubMed ID: 1100900
[TBL] [Abstract][Full Text] [Related]
15. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of spontaneous and antibody-dependent cellular cytotoxicity by sera and isolated antiglobulin preparations from rheumatoid arthritis patients.
Fink PC; Schedel I; Peter HH; Deicher H
Scand J Immunol; 1977; 6(3):173-83. PubMed ID: 300499
[TBL] [Abstract][Full Text] [Related]
17. Perfusion of canine serum over Staphylococcus aureus Cowan 1: Evidence for release of protein A and changes in specific antibody activity.
Balint J; Jones FR
Immunol Commun; 1983; 12(6):573-91. PubMed ID: 6609117
[TBL] [Abstract][Full Text] [Related]
18. Elution of cytomegalovirus antibodies from adenocarcinoma of the colon.
Grail A; Norval M
Gut; 1985 Oct; 26(10):1053-8. PubMed ID: 2996990
[TBL] [Abstract][Full Text] [Related]
19. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
[No Abstract] [Full Text] [Related]
20. Tumor growth inhibition by protein A and non-protein A containing Staphylococcus aureus in a mouse mammary carcinoma model.
Langvad E; Espersen F; Briand P
Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):255-9. PubMed ID: 6516852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
